Beaumont Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $232K | Buy |
2,095
+10
| +0.5% | +$1.11K | 0.02% | 341 |
|
|
2025
Q1 | $234K | Buy |
+2,085
| New | +$234K | 0.02% | 330 |
|
|
2022
Q2 | – | Sell |
-6,278
| Closed | -$373K | – | 327 |
|
|
2022
Q1 | $373K | Buy |
6,278
+27
| +0.4% | +$1.6K | 0.03% | 243 |
|
|
2021
Q4 | $454K | Buy |
6,251
+117
| +2% | +$8.5K | 0.03% | 228 |
|
|
2021
Q3 | $428K | Sell |
6,134
-101
| -2% | -$7.05K | 0.03% | 222 |
|
|
2021
Q2 | $429K | Hold |
6,235
| – | – | 0.03% | 232 |
|
|
2021
Q1 | $403K | Sell |
6,235
-96
| -2% | -$6.21K | 0.03% | 224 |
|
|
2020
Q4 | $369K | Sell |
6,331
-388
| -6% | -$22.6K | 0.03% | 236 |
|
|
2020
Q3 | $425K | Buy |
6,719
+381
| +6% | +$24.1K | 0.04% | 208 |
|
|
2020
Q2 | $488K | Buy |
6,338
+132
| +2% | +$10.2K | 0.05% | 180 |
|
|
2020
Q1 | $464K | Buy |
+6,206
| New | +$464K | 0.06% | 149 |
|
|
2018
Q4 | – | Sell |
-4,134
| Closed | -$319K | – | 212 |
|
|
2018
Q3 | $319K | Buy |
+4,134
| New | +$319K | 0.03% | 181 |
|
|
2016
Q2 | – | Sell |
-17,125
| Closed | -$1.68M | – | 149 |
|
|
2016
Q1 | $1.68M | Sell |
17,125
-72,989
| -81% | -$7.16M | 0.27% | 74 |
|
|
2015
Q4 | $9.12M | Buy |
90,114
+21,914
| +32% | +$2.22M | 1.5% | 27 |
|
|
2015
Q3 | $7.99M | Hold |
68,200
| – | – | 1.16% | 37 |
|
|
2015
Q2 | $7.99M | Buy |
68,200
+50,525
| +286% | +$5.92M | 1.16% | 37 |
|
|
2015
Q1 | $1.73M | Buy |
17,675
+3,421
| +24% | +$336K | 0.06% | 89 |
|
|
2014
Q4 | $1.34M | Buy |
14,254
+12,055
| +548% | +$1.14M | 0.06% | 92 |
|
|
2014
Q3 | $234K | Buy |
+2,199
| New | +$234K | 0.02% | 146 |
|